http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Novo Nordisk surges to success, but will it survive unscathed?
Novo Nordisk, a pharmaceutical company based in Denmark, has boosted its home country's financial state thanks to its widely publicized weight loss drugs, Wegovy and Ozempic. While consumer response to the medicines has been overwhelming, it remains to be seen whether the company can sustain its massive growth in the long term. This case study examines how Novo Nordisk could impact not only the pharmaceutical world but also Denmark's overall economy.